204 related articles for article (PubMed ID: 26091081)
41. Development of a bivalent conjugate vaccine candidate against rotaviral diarrhea and tuberculosis using polysaccharide from Mycobacterium tuberculosis conjugated to ΔVP8* protein from rotavirus.
Park WJ; Yoon YK; Kim Y; Park JS; Pansuriya R; Cho SN; Seok YJ; Ganapathy R
Vaccine; 2021 Oct; 39(45):6644-6652. PubMed ID: 34642087
[TBL] [Abstract][Full Text] [Related]
42. Distribution of conserved and specific epitopes on the VP8 subunit of rotavirus VP4.
Larralde G; Gorziglia M
J Virol; 1992 Dec; 66(12):7438-43. PubMed ID: 1279204
[TBL] [Abstract][Full Text] [Related]
43. Cloning, expression, and purification of recombinant bovine rotavirus hemagglutinin, VP8*, in Escherichia coli.
Favacho AR; Kurtenbach E; Sardi SI; Gouvea VS
Protein Expr Purif; 2006 Apr; 46(2):196-203. PubMed ID: 16275130
[TBL] [Abstract][Full Text] [Related]
44. Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice.
He F; Prabakaran M; Rajesh Kumar S; Tan Y; Kwang J
Antiviral Res; 2014 May; 105():143-51. PubMed ID: 24637255
[TBL] [Abstract][Full Text] [Related]
45. Porcine rotavirus strain Gottfried-based human rotavirus candidate vaccines: construction and characterization.
Hoshino Y; Jones RW; Ross J; Kapikian AZ
Vaccine; 2005 May; 23(29):3791-9. PubMed ID: 15893616
[TBL] [Abstract][Full Text] [Related]
46. Tandem copies of a human rotavirus VP8 epitope can induce specific neutralizing antibodies in BALB/c mice.
Kovacs-Nolan J; Mine Y
Biochim Biophys Acta; 2006 Dec; 1760(12):1884-93. PubMed ID: 16978788
[TBL] [Abstract][Full Text] [Related]
47. Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses.
Luo G; Zeng Y; Yang H; Li Y; Yang L; Li C; Song F; Zhang S; Li T; Ge S; Zhang J; Xia N
iScience; 2022 Oct; 25(10):105099. PubMed ID: 36185383
[TBL] [Abstract][Full Text] [Related]
48. Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq.
Zeller M; Patton JT; Heylen E; De Coster S; Ciarlet M; Van Ranst M; Matthijnssens J
J Clin Microbiol; 2012 Mar; 50(3):966-76. PubMed ID: 22189107
[TBL] [Abstract][Full Text] [Related]
49. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
50. VP7 and VP4 genotypes of rotaviruses cocirculating in Iran, 2015 to 2017: Comparison with cogent sequences of Rotarix and RotaTeq vaccine strains before their use for universal mass vaccination.
Motamedi-Rad M; Farahmand M; Arashkia A; Jalilvand S; Shoja Z
J Med Virol; 2020 Aug; 92(8):1110-1123. PubMed ID: 31774174
[TBL] [Abstract][Full Text] [Related]
51. mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents.
Roier S; Mangala Prasad V; McNeal MM; Lee KK; Petsch B; Rauch S
NPJ Vaccines; 2023 Dec; 8(1):190. PubMed ID: 38129390
[TBL] [Abstract][Full Text] [Related]
52. Phylogenetic analysis of the viral proteins VP4/VP7 of circulating human rotavirus strains in China from 2016 to 2019 and comparison of their antigenic epitopes with those of vaccine strains.
Mao T; Wang M; Wang J; Ma Y; Liu X; Wang M; Sun X; Li L; Li H; Zhang Q; Li D; Duan Z
Front Cell Infect Microbiol; 2022; 12():927490. PubMed ID: 36004332
[TBL] [Abstract][Full Text] [Related]
53. Protective immunity following vaccination with a recombinant multiple-epitope protein of bovine herpesvirus type I in a rabbit model.
Wen X; Tong X; Wang M; Wang J; Ni H; Ran X
Appl Microbiol Biotechnol; 2020 Apr; 104(7):3011-3023. PubMed ID: 32002602
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the efficacy of rotavirus VLP vaccines to a live homologous rotavirus vaccine in a pig model of rotavirus disease.
El-Attar L; Oliver SL; Mackie A; Charpilienne A; Poncet D; Cohen J; Bridger JC
Vaccine; 2009 May; 27(24):3201-8. PubMed ID: 19446192
[TBL] [Abstract][Full Text] [Related]
55. Dual Recognition of Sialic Acid and αGal Epitopes by the VP8* Domains of the Bovine Rotavirus G6P[5] WC3 and of Its Mono-reassortant G4P[5] RotaTeq Vaccine Strains.
Alfajaro MM; Kim JY; Barbé L; Cho EH; Park JG; Soliman M; Baek YB; Kang MI; Kim SH; Kim GJ; Park SI; Pendu JL; Cho KO
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243129
[TBL] [Abstract][Full Text] [Related]
56. Binding specificity of P[8] VP8* proteins of rotavirus vaccine strains with histo-blood group antigens.
Sun X; Guo N; Li D; Jin M; Zhou Y; Xie G; Pang L; Zhang Q; Cao Y; Duan ZJ
Virology; 2016 Aug; 495():129-35. PubMed ID: 27209447
[TBL] [Abstract][Full Text] [Related]
57. S1 domain of the porcine epidemic diarrhea virus spike protein as a vaccine antigen.
Makadiya N; Brownlie R; van den Hurk J; Berube N; Allan B; Gerdts V; Zakhartchouk A
Virol J; 2016 Apr; 13():57. PubMed ID: 27036203
[TBL] [Abstract][Full Text] [Related]
58. Experimental studies of a vaccine formulation of recombinant human VEGF antigen with aluminum phosphate.
Pérez Sánchez L; Morera Díaz Y; Bequet-Romero M; Ramses Hernández G; Rodríguez Y; Castro Velazco J; Puente Pérez P; Ayala Avila M; Gavilondo JV
Hum Vaccin Immunother; 2015; 11(8):2030-7. PubMed ID: 25891359
[TBL] [Abstract][Full Text] [Related]
59. Preclinical and clinical development of a dengue recombinant subunit vaccine.
Manoff SB; George SL; Bett AJ; Yelmene ML; Dhanasekaran G; Eggemeyer L; Sausser ML; Dubey SA; Casimiro DR; Clements DE; Martyak T; Pai V; Parks DE; Coller BA
Vaccine; 2015 Dec; 33(50):7126-34. PubMed ID: 26458804
[TBL] [Abstract][Full Text] [Related]
60. Sequence analysis of VP7 and VP4 genes of G1P[8] rotaviruses circulating among diarrhoeic children in Pune, India: a comparison with Rotarix and RotaTeq vaccine strains.
Kulkarni R; Arora R; Arora R; Chitambar SD
Vaccine; 2014 Aug; 32 Suppl 1():A75-83. PubMed ID: 25091685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
